openPR Logo
Press release

Platelet Rich Plasma Market Will Weather the Storm by 2023 as it is Expected to Reach US$110.0 mn by the end of 2023

01-18-2017 04:49 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Platelet Rich Plasma Market Will Weather the Storm by 2023 as it

The platelet rich plasma market in Asia Pacific represents a semi-consolidated competitive landscape. According to a new study by Transparency Market Research (TMR), the top five companies in the market, including Harvest Technologies, Arthrex, Inc., Zimmer Biomet, DePuy Synthes, and Stryker accounted for approximately 79% of the Asia Pacific platelet rich plasma market in 2014. Of these, Harvest Technology, a subsidiary of Terumo Corporation led the Asia Pacific PRP market in 2014, holding a share of over 25%.

Enterprises Engaged in Sales of PRP devices Gain from Rising Medical Tourism in Asia Pacific

The recent advances in PRP devices owing to the increasing research and development activities have bolstered the demand for PRP therapy. Additionally, the rising prevalence of orthopedic diseases, sports injuries, neurological disorders, obesity, and cardiovascular diseases has been boosting the Asia Pacific platelet rich plasma market. “With millions opting for cosmetic surgeries globally, prospects for growth of the Asia Pacific PRP market seem quite impressive in the forthcoming years,” said a lead analyst at TMR.

In the last few years, Asia Pacific has emerged at the fore of the medical tourism industry. The region has witnessed rapid advancements in healthcare, which have catapulted it as a major destination for cosmetic surgeries at affordable price. The TMR analyst says, “With millions of people exploring options for non-invasive cosmetic surgeries, medical tourism is expected to surge in Asia Pacific, thus boosting demand for PRP from the region.” Besides this, the widespread use of platelet rich plasma is also expected to accelerate growth of the market.

Among other drivers, the rising awareness about PRP devices across emerging nations will boost PRP sales in Asia Pacific. However, the rapid commercialization of treatments has increased prices of PRP. This has emerged as a major bottleneck hindering growth of the platelet rich plasma market in Asia Pacific. Furthermore, increasing awareness regarding threats commonly associated with the use of PRP also limits the PRP sales to an extent.

Nevertheless, with the advent of novel applications of PRP technologies, leading enterprises offering PRP products and devices will witness new opportunities to capitalize on. These companies are also expected to considerably gain from the evolution of the latest devices.

China and Australia Emerge as Most Lucrative Markets for PRP in Asia Pacific

Regionally, China and Australia have emerged as the most lucrative markets for platelet rich plasma products and devices in Asia Pacific. Both these regions boast a well-established healthcare infrastructure. This, combined with the increasing investment in research and development and high awareness pertaining to uses of PRP, will accelerate PRP sales in Asia Pacific.

China presently accounts for the leading share in the Asia Pacific platelet rich plasma market, followed by Australia and South Korea, in that order. India currently holds only a small share in the market. However, in the next few years, PRP demand from the country is likely to increase at a robust pace. The increasing geriatric population and presence of many skilled doctors in the country will augment demand for PRP in India.

Rise in Orthopedic Surgeries to Boost Demand for PRP

By application, orthopedic surgeries accounted for the highest demand for platelet rich plasma in Asia Pacific. Demand for PRP in the cosmetic surgeries is also expected to increase rapidly in the forthcoming years. Furthermore, the Asia Pacific market for PRP is also expected to significantly gain from the increasing use of platelet rich plasma as a substitute of derma fillers.

Transparency Market Research has pegged the overall value of the Asia Pacific platelet rich plasma market to reach US$110.0 mn by the end of 2023. The market stood at US$30 mn in 2014 and is expected to rise at an impressive CAGR of 15.4% between 2015 and 2023.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Platelet Rich Plasma Market Will Weather the Storm by 2023 as it is Expected to Reach US$110.0 mn by the end of 2023 here

News-ID: 416278 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for PRP

Therapeutic PRP Tubes Market to Witness Growth at a 6.6% CAGR by 2031 | Regen La …
QYResearch A newly published report titled "Global Therapeutic PRP Tubes Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Therapeutic PRP Tubes market. For instance, the market dynamics section digs deep into the
Global PRP Centrifuges Market Research Report 2023-2029
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global PRP Centrifuges Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global PRP Centrifuges market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides advanced statistics
Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth. The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.